A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive diseasePaola Papaldo, F. Cognetti, Maria Simona Pino et al.|Annals of Oncology|2006Cited by 82
Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patientsAlessandra Fabi, F. Cognetti, G. Ferretti et al.|Cancer Chemotherapy and Pharmacology|2005Cited by 20
EGFR Gene Copy Number and Response to Lapatinib/Capecitabine in HER2 Positive Metastatic Breast Cancer Patients Pretreated with Trastuzumab.Alessandra Fabi, Francesco Cognetti, Erika Vico et al.|Cancer Research|2009Cited by 0